Ionis Pharmaceuticals, Inc. Total Long-Term Debt
Ionis Pharmaceuticals, Inc. (IONS) had Total Long-Term Debt of $1.81 billion as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2026-02-26
- 2025-12-31: Long-term Debt $1.81B.
- 2024-12-31: Long-term Debt $1.25B.
- 2023-12-31: Long-term Debt $1.31B.
- 2022-12-31: Long-term Debt $1.19B.
| Period end | Long-term Debt |
|---|---|
| 2025-12-31 | $1.81B 10-K · filed 2026-02-26 |
| 2024-12-31 | $1.25B 10-K · filed 2025-02-19 |
| 2023-12-31 | $1.31B 10-K · filed 2024-02-21 |
| 2022-12-31 | $1.19B 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |